Income Taxes (Tables)

12 Months Ended

Dec. 31, 2013

Income Tax Disclosure [Abstract]

Schedule of deferred tax assets (liabilities)

As of December 31, 2013 and 2012, the approximate income tax effect of the Company’s deferred tax assets (liabilities) consisted of the following:

	2013		2012
Deferred tax asset:
Tax effect of:
Net operating loss carryforwards	$	25,504,000	$	27,926,000
Accrued expenses		49,000		21,000
Amortization of definite lived intangible assets		15,000		16,000
Non-qualified stock option compensation		69,000		248,000
Depreciation		123,000		121,000
Other		297,000		227,000
Patents		(114,000)		(158,000)
State net operating loss carryforwards, net of federal tax benefit		19,000		428,000
Research tax credit carryforwards		2,223,000		2,080,000
Total deferred tax assets		28,185,000		30,909,000
Valuation allowance		(28,185,000)		(30,909,000)
Net deferred tax assets	$	-	$	-

Schedule of Effective Income Tax Rate Reconciliation

The benefit for income taxes differs from the federal statutory rate due to the following:

	2013		2012
Tax at statutory rate	(34.0)	%	(34.0)	%
State taxes, net of federal benefit	0.0		0.0
Research and development credit	(1.7)		0.1
Share based payment expense	0.7		0.9
Other	3.0		1.4
Removal of deferred tax asset on federal net operating losses	64.1		26.9
Establishment of deferred tax asset on state net operating      losses and state deferred taxes, net of federal income tax      benefits	6.4		(9.6)
Change in valuation allowance	(38.6)		14.3
Effective tax rate	0.0	%	0.0	%